5AM Venture Management as of March 31, 2024
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 26 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Enliven Therapeutics (ELVN) | 15.1 | $68M | 3.8M | 17.59 | |
| Entrada Therapeutics (TRDA) | 14.0 | $63M | 4.4M | 14.17 | |
| Dianthus Therapeutics (DNTH) | 8.3 | $37M | 1.2M | 30.00 | |
| Merus N V (MRUS) | 5.5 | $25M | 549k | 45.03 | |
| Celldex Therapeutics Com New (CLDX) | 4.7 | $21M | 497k | 41.97 | |
| Praxis Precision Medicines I Com New (PRAX) | 4.6 | $21M | 340k | 61.02 | |
| Viking Therapeutics (VKTX) | 4.4 | $20M | 238k | 82.00 | |
| Pharvaris N V (PHVS) | 4.1 | $18M | 798k | 23.11 | |
| Biohaven (BHVN) | 3.9 | $18M | 320k | 54.69 | |
| Avidity Biosciences Ord (RNA) | 3.8 | $17M | 666k | 25.52 | |
| Tyra Biosciences (TYRA) | 3.4 | $15M | 939k | 16.40 | |
| Vor Biopharma (VOR) | 3.4 | $15M | 6.4M | 2.37 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 3.2 | $14M | 282k | 50.23 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 3.1 | $14M | 1.2M | 11.30 | |
| Miragen Therapeutics (VRDN) | 2.9 | $13M | 737k | 17.51 | |
| Silence Therapeutics Ads (SLN) | 2.3 | $10M | 476k | 21.60 | |
| Anaptysbio Inc Common (ANAB) | 1.8 | $8.1M | 358k | 22.52 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.7 | $7.7M | 490k | 15.76 | |
| Adverum Biotechnologies Com New (ADVM) | 1.7 | $7.7M | 542k | 14.14 | |
| Rallybio Corp (RLYB) | 1.5 | $6.7M | 3.6M | 1.85 | |
| Gh Research Ordinary Shares (GHRS) | 1.4 | $6.1M | 573k | 10.66 | |
| Scpharmaceuticals (SCPH) | 1.3 | $6.0M | 1.2M | 5.02 | |
| Mersana Therapeutics (MRSN) | 1.3 | $5.8M | 1.3M | 4.48 | |
| Cogent Biosciences (COGT) | 1.2 | $5.3M | 790k | 6.72 | |
| Q32 Bio (QTTB) | 1.0 | $4.3M | 252k | 17.04 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $1.0M | 1.1M | 0.92 |
